Clinical Trial Update: Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing gabapentin to standard of care for preventing mucositis in patients with stage III-IV head and neck cancer undergoing chemoradiation; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Mucositis

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Malignant Head and Neck Neoplasm, Mucositis | Phase 3 | Status: COMPLETED | Results posted: 2020-09-24